Lv41
610 积分 2026-06-25 加入
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
8小时前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
8小时前
已完结
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP
2个月前
已完结
皖公网安备34019202002308
